Topic Anticoagulation
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Venous Thromboembolism Risk Assessment and Prophylaxis: Facilitators and Barriers to Compliance with Clinical Guidelines in Acute Care
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: JBIBP0419Published: April 2019Expires: 12/31/2026Sources: JBI Best Practice Interactive Clinical Courses , Joanna Briggs Institute Evidence Best Practice ModulesDetailsRequired Passing Score: 7/10 (70%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Direct Oral Anticoagulants in Patients Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0419Published: April 2019Expires: 12/31/2026Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Advanced Practice Nursing , CancerSpecialties: Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Treatment with Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran with Idarucizumab: A Case Study
Price: $12.95Credits:
- ANCC 1.0 CH / 1.0 APH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: JNN0119Published: Jan 2019Expires: 12/31/2026Sources: Journal of Neuroscience NursingDetailsRequired Passing Score: 13/18 (72%)Specialties: Neurology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Review on the New and Old Anticoagulants
Price: $15.00Credits:
- ANCC 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: ON0119DPublished: Jan/Feb 2019Expires: 12/31/2026Sources: Orthopaedic NursingDetailsRequired Passing Score: 14/20 (70%)Categories: Advanced Pharmacology Hours , Advanced Practice NursingSpecialties: Orthopaedics -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Reversal Agents for Oral Anticoagulants
Price: $17.95Credits:
- ANCC 1.5 CH / 1.5 CH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: NP1117APublished: Nov 2017Expires: 12/31/2026DetailsRequired Passing Score: 13/18 (72%)Specialties: Primary Care -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Oral Antiplatelet Medications
Price: $17.95Credits:
- ANCC 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: NP0817APublished: Aug 2017Expires: 12/31/2026DetailsRequired Passing Score: 13/18 (72%)Specialties: Primary Care -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Venous Thromboembolism: Updated Management Guidelines
Price: $17.95Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: AJN0517BPublished: May 2017Expires: 12/31/2026Sources: AJN, American Journal of NursingDetailsRequired Passing Score: 14/20 (70%)Specialties: Evidence-based practice, Medical-Surgical -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2016, Part 2
Price: $27.95Credits:
- ANCC 3.0 CH / 3.0 APH
- DC - BON 3.0 CH
- KY-BON 3.0 CH
- GA - BON 3.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: N0716APublished: Jul 2016Expires: 12/31/2026Sources: Nursing2020DetailsRequired Passing Score: 13/18 (72%)Specialties: Primary Care, Women's Health -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} An Overview of Antithrombotics in Ischemic Stroke
Price: $24.95Credits:
- ANCC 2.5 CH / 2.5 APH
- DC - BON 2.5 CH
- KY-BON 2.5 CH
- GA - BON 2.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: NP0616APublished: Jun 2016Expires: 12/31/2026DetailsRequired Passing Score: 13/18 (72%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Antidote Is Finally Here! Idarucizumab, A Specific Reversal Agent for the Anticoagulant Effects of Dabigatran
Price: $21.95Credits:
- ANCC 2.0 CH / 2.0 APH
- DC - BON 2.0 CH
- KY-BON 2.0 CH
- GA - BON 2.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNS0316Published: Mar/Apr 2016Expires: 12/31/2026DetailsRequired Passing Score: 13/18 (72%)